MondayNightIBD Future Targets & PROs in Crohn's: Expert Video
December 16, 2024 ~ Marla Dubinsky, MD
Post-Survey & Application for CME Credit

In order to receive credit for this activity, you must read the front matter, view the activity, achieve a passing of at least 100% on this post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements.

There is no fee to participate in this activity.

Question Title

* 1. What are your specialty & credentials?

IBD Specialist

General GI

Colorectal Surgeon

Fellow/Trainee

APP

Nurse

PharmD

Other (please specify)

Question Title

* 2. What is your community of practice?

Academic

Community

Industry

Other (please specify)

Question Title

* 3. In the CONFIDE study that assessed the impact of mod-sev #Crohns symptoms, what % of surveyed patients reported having stool urgency and wearing a diaper more than once a week?

<10%

20%

40%

50%

Question Title

* 4. 22 year old with new diagnosis of Crohn’s ileitis. She read online about all the potential complication of Crohn’s and ask how she can decrease her risk with the right therapy. Her lowest risk of disease progression is achieved with a therapy that puts her in

Clinical remission

Endoscopic/mucosal healing

Histological healing

Transmural healing

EVALUATION FORM

Question Title

* 5. Upon completion of this activity, I am able to:

	Strongly agree	Agree	Disagree	Strongly disagree
ASSESS the role of transmural healing and histological healing assessment as treatment targets in Crohn’s disease when evaluating a patient’s response to treatment	ASSESS the role of transmural healing and histological healing assessment as treatment targets in Crohn’s disease when evaluating a patient’s response to treatment Strongly agree	ASSESS the role of transmural healing and histological healing assessment as treatment targets in Crohn’s disease when evaluating a patient’s response to treatment Agree	ASSESS the role of transmural healing and histological healing assessment as treatment targets in Crohn’s disease when evaluating a patient’s response to treatment Disagree	ASSESS the role of transmural healing and histological healing assessment as treatment targets in Crohn’s disease when evaluating a patient’s response to treatment Strongly disagree
EVALUATE the importance of PROs, particularly bowel urgency, on patient’s quality of life as a treatment targets in Crohn’s disease	EVALUATE the importance of PROs, particularly bowel urgency, on patient’s quality of life as a treatment targets in Crohn’s disease Strongly agree	EVALUATE the importance of PROs, particularly bowel urgency, on patient’s quality of life as a treatment targets in Crohn’s disease Agree	EVALUATE the importance of PROs, particularly bowel urgency, on patient’s quality of life as a treatment targets in Crohn’s disease Disagree	EVALUATE the importance of PROs, particularly bowel urgency, on patient’s quality of life as a treatment targets in Crohn’s disease Strongly disagree

Question Title

* 6. Please indicate the extent of your agreement with the following statements:

	Strongly agree	Agree	Disagree	Strongly disagree
The faculty for this activity were effective	The faculty for this activity were effective Strongly agree	The faculty for this activity were effective Agree	The faculty for this activity were effective Disagree	The faculty for this activity were effective Strongly disagree

Question Title

* 7. Overall, was this activity fair, balanced and free from commercial bias?

Yes

Question Title

* 8. If no, please explain:

Question Title

* 9. Of the patients with IBD you will see in the next month, about how many will benefit from the information you learned today?

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 10. Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):

Consider non-invasive imaging techniques for assessing IBD disease activity

Consider transmural healing as a treatment target for Crohn's

Ask patients with Crohn's disease if they experience urgency and how often

Ask patients with Crohn's disease if they need to wear protective undergarments or pads

I do not plan on making changes to my practice at this time

Other (explain)

Question Title

* 11. Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):

Lack of knowledge regarding imaging and disease monitoring options (patient-related)

Limited knowledge and training regarding new imaging and treatment techniques for Crohn's disease (provider-level barrier)

Lack of time resources to consider change (practice-related barrier)

Inadequate support staff for pt education/insurance/billing/administrative issues (practice-level barrier)

Insurance reimbursement or legal issues (systems-related barrier)

Lack of access to novel imaging devices due to regulatory approvals/insurance coverage (systems-related barrier)

Other (please specify)

Question Title

* 12. For purposes of certification, you must complete the following information.
Please note that we will not forward or sell your contact information.

First Name *

Last Name *

Degree/Credentials:

City

State/Province

ZIP/Postal Code *

Country

Email Address (required to receive credit) *

Question Title

* 13. I certify that I have participated in the continuing education activity entitled, "MondayNightIBD | Histologic Assessment & Patient Reported Outcomes Measures in Crohn's Disease" and claim 0.5 AMA PRA Category 1 Credit^TM.

Yes

Thank you for participating in our activity and completing the necessary paperwork. Your certificate will be emailed to you using the email address provided above. Please allow 4 weeks to receive your certificate.

For additional information about the accreditation of this activity, please visit https://www.partnersed.com

MondayNightIBD Future Targets & PROs in Crohn's: Expert VideoDecember 16, 2024 ~ Marla Dubinsky, MD***Post-Survey & Application for CME Credit***

Question Title

* 1. What are your specialty & credentials?

Question Title

* 2. What is your community of practice?

Question Title

* 3. In the CONFIDE study that assessed the impact of mod-sev #Crohns symptoms, what % of surveyed patients reported having stool urgency and wearing a diaper more than once a week?

Question Title

* 4. 22 year old with new diagnosis of Crohn’s ileitis. She read online about all the potential complication of Crohn’s and ask how she can decrease her risk with the right therapy. Her lowest risk of disease progression is achieved with a therapy that puts her in

Question Title

* 5. Upon completion of this activity, I am able to:

Question Title

* 6. Please indicate the extent of your agreement with the following statements:

Question Title

* 7. Overall, was this activity fair, balanced and free from commercial bias?

Question Title

* 8. If no, please explain:

Question Title

* 9. Of the patients with IBD you will see in the next month, about how many will benefit from the information you learned today?

Question Title

* 10. Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):

Question Title

* 11. Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):

Question Title

* 12. For purposes of certification, you must complete the following information. *Please note that we will not forward or sell your contact information.*

Question Title

* 13. I certify that I have participated in the continuing education activity entitled, "MondayNightIBD | Histologic Assessment & Patient Reported Outcomes Measures in Crohn's Disease" and claim 0.5 AMA PRA Category 1 CreditTM.

MondayNightIBD Future Targets & PROs in Crohn's: Expert Video
December 16, 2024 ~ Marla Dubinsky, MD
Post-Survey & Application for CME Credit

* 12. For purposes of certification, you must complete the following information.
Please note that we will not forward or sell your contact information.

* 13. I certify that I have participated in the continuing education activity entitled, "MondayNightIBD | Histologic Assessment & Patient Reported Outcomes Measures in Crohn's Disease" and claim 0.5 AMA PRA Category 1 Credit^TM.